← All indications
Autism Spectrum Disorder
Wide continuum of associated cognitive and neurobehavioral disorders, including, but not limited to, three core-defining features: impairments in socialization, impairments in verbal and nonverbal communication, and restricted and repetitive patterns of behaviors. (from DSM-V)
Subtype terms (2)
More specific conditions that are subtypes of Autism Spectrum Disorder in the MeSH hierarchy.
- Asperger Syndrome
12 drugs approved
- Autistic Disorder
109 drugs (70 approved, 39 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (17)
Phase 3 trials (21)
Phase 2 trials (68)
- azd-7325
- pitolisant
- bifidobacterium animalis
- ketamine
- diphenhydramine
- edaravone
- valproic acid
- suvorexant
- vatiquinone
- essential oils
- escitalopram
- sertraline
- mecasermin
- bioactive factors, produced by m2 macrophage
- esketamine
- jnj-42165279
- l1-79
- tideglusib
- olanzapine
- donepezil
- saccharomyces boulardii
- propranolol
- ro5285119
- growth hormone
- stem cells
- suramin
- tramadol
- clonidine
- vancomycin
- zolpidem
- +38 more
Phase 1 trials (14)
Other trials (36)
- propofol
- vitamin e
- arachidonic acid
- dark chocolate
- platelet-rich plasma
- vitamin c
- cow milk
- safflower oil
- sapropterin
- sodium butyrate
- buprenorphine
- sufentanil
- tianeptine
- fluconazole
- ubiquinol
- bergamot oil
- clostridium butyricum
- creatine
- date fruit
- lactobacillus plantarum
- vivomixx
- lovastatin
- vitamin a
- baclofen
- fish oil
- docosahexaenoic acid
- phosphatidylserine
- Lactobacillus acidophilus
- b multivitamins
- zinc
- +6 more
Organizations
Organization Involved with Phase 4 Indications (31)
- Shire
- Bio Products Laboratory
- Forest Laboratories
- Eli Lilly
- Isaac Melamed
- IRCCS Fondazione Stella Maris
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- University of Pittsburgh
- Harvard University
- Duke University
- Emory University
- University of Washington
- JPM van Stralen Medicine Professional
- Katholieke Universiteit Leuven
- Ohio State University
- University of Nebraska
- University of Rochester
- Yale University
- University of California, Los Angeles
- IMMUNOe
- University of North Carolina at Chapel Hill
- Vita-Salute University of Milano. Italy
- Washington University in St. Louis
- Massachusetts Institute of Technology
- Istituto di Fisiologia Clinica CNR
- American Psychiatric Association
- Yeshiva University
- Government of Italy
- Government of Singapore
- +1 more
Organization Involved with Phase 3 Indications (26)
- Bristol-Myers Squibb
- Servier
- Roche
- Neurim Pharmaceuticals Ltd.
- Seaside Therapeutics, Inc.
- Otsuka
- Nobel Pharmaceuticals
- Indiana University
- Mclean Hospital
- University of Toronto
- University of Arkansas
- Columbia University
- Kurume University
- University of California, San Diego
- University of California, San Francisco
- University of Cincinnati
- Vanderbilt University
- Department of Defense
- Janssen Pharmaceutica NV
- University of Sao Paulo
- University of Paris
- Autism Speaks
- Lundbeck
- Johnson and Johnson
- Assistance Publique - Hôpitaux de Paris
- Wholistic Research and Education Foundation
Organization Involved with Phase 2 Indications (73)
- Bioelectron
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Immunotec Inc.
- OptiNose AS
- The EMMES Corporation
- Sutter Medical Foundation
- Children's Hospital of Philadelphia
- University of Pennsylvania
- University of Arizona
- Arizona State University
- Guangzhou Medical University
- Hamamatsu University
- Hoosier Cancer Research Network
- Hospital General Universitario Gregorio Marañon
- Johns Hopkins University
- McMaster University
- Minia University
- New York University
- Newcastle University
- Northwestern University
- Nova Southeastern University
- Osaka University
- Queen's University, Belfast
- Russian Academy of Medical Sciences
- Rutgers University
- Stanford University
- Stanley Medical Research Institute
- University of Edinburgh
- University of Glasgow
- University of Louisville
- +43 more
Organization Involved with Phase 1 Indications (20)
- Allergan
- Sponsor GmbH
- Institute for Neurodegenerative Disorders
- Sutter Health
- University of Reading
- University of Missouri
- Vanda Pharmaceuticals
- Pennsylvania State University
- Department of Veteran Affairs
- Thrasher Research Fund
- Clasado Biosciences
- Roivant Sciences, Inc.
- Cures Within Reach
- Perkin Elmer Inc.
- Fundatia Bio-Forum
- Children's Hospital Los Angeles
- Spitalul Angiomedica
- ProgenaBiome
- Ventura Clinical Trials
- Sun Genomics
Organization Involved with Other Experimental Indications (23)
- Biomarin
- National Center for Complementary and Integrative Health (NCCIH)
- National Institute of Nursing Research (NINR)
- Central South University
- University of London
- Loma Linda University
- McGill University
- The Center for Autism and Related Disorders
- University of Medicine and Dentistry of New Jersey
- University of Messina
- University of Rome Tor Vergata
- University of Bari
- University of California, Berkeley
- Sun Yat-Sen University
- Brain & Behavior Research Foundation
- Organization for Autism Research
- Thoughtful House
- University of Novi Sad
- Franklin Institute of Wellness
- University of Coimbra
- Universidad de Cordoba
- Associazione Italiana Sindrome di Phelan-McDermid (AISPHEM)
- Mackay Medical College